Kirkland Advises WindRose Health Investors on $2.6 Billion Fund VII
Kirkland & Ellis advised WindRose Health Investors, LLC, a New York-based healthcare private equity firm, on the formation of its seventh fund, WindRose Health Investors VII, L.P. (Fund VII), with $2.6 billion in limited partner and general partner commitments. The fund closed at its hard cap and significantly exceeded the size of Fund VI, its $1.4 billion predecessor fund. Fund VII expects to close on its first two acquisitions by year-end 2025 and is targeting 11-13 investments in total.
The Kirkland team included investment funds lawyers Sean Malone, Andrew Wright, Aura Gilham, Christine Lee, Danny Cundiff, Daisy An and Muskan Sharma; tax lawyers Elie Zolty, Claire Oxford and Daniella Wenger; and investment funds regulatory lawyer Mac Laban.
